Davis Stephen
CIK 0001131146
CEODirector
Filings
21
Latest Aug 20, 2024
Issuers covered
2
Showing
21 of 21
Page 1
Track record
18 of 18 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 18 | 50% | +0.9% | -1.0% | +29.7% | -17.4% |
| 90 days | 18 | 56% | +3.0% | +8.3% | +41.7% | -38.1% |
| 180 days | 18 | 61% | +4.1% | +12.1% | +45.8% | -51.4% |
| 365 days | 18 | 78% | +8.6% | +21.7% | +44.0% | -81.9% |
Issuers
Companies where Davis Stephen has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ACAD | Acadia Pharmaceuticals Inc | 18 | Aug 20, 2024 |
| BLCM | Bellicum Pharmaceuticals, Inc | 3 | Jan 5, 2023 |
All filings
21 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|